SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: luis a. garcia who wrote (384)8/15/1997 1:42:00 PM
From: M.LUTH   of 1115
 
Luis remember back about 3-4 years when BI research news letter had Lidak featured? They had LDAKA pegged at $50.0/share, now that trials are good and they start selling this stuff! who knows what the price will go to. Anybody care to chime with a quess in say 2 years. BI was only going with numbers based on Lidakol and now that they have so much else to offer? I did not know that as soon as they file they coud get approval in a couple of days, is this true? You also say that if true they can start selling this stuff in 3-4 months, that would be great. I never thought I would say this, but I hope lots of people get herpes and need a good drug to fix them up. Lots of activity today kind of sucks that they pick a bad week in the market to release results. GO LLLLLLLLLLLLLLIDAK Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext